 Companys annualized revenues and be immediately accretive to Applied UVs earnings per share Continues the acquisition strategy by Applied UV to acquire and consolidate air and pathogen disinfection industry Company expects to be EBITDA positive during Q1 2022 Product portfolio includes patented 247 large air volume, whole room UV-C pathogen killing technology Distribution for North America with one of the largest distributors of healthcare supplies which supports accelerated adoption and top-line growth Since 2015, Scientific Air and its predecessor has been making air safer in hundreds of hospitals nationwide with no harmful byproducts Substantially deepens Applied UVs infection prevention product portfolio with mobile application and expands platform for growth Execution of managements two pronged top and bottom-line strategy: support organic growth of products with immediately accretive and innovative inorganic growth open up North America market for all our pathogen destroying products while expanding the international portfolio Applied UV to host investor call at 9:00 am EDT on October 14, 2021 MOUNT VERNON, NY ACCESSWIRE October 14, 2021 Applied UV, Inc. NASDAQ:AUVI Applied UV or the Company, an infection control technology company that applies the power of narrow-range ultraviolet light UVC for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced it has closed on the acquisition by its wholly-owned subsidiary, SteriLumen, Inc. SteriLumen, of substantially all of the assets of privately-held Scientific Air Management Scientific Air, of Pompano Beach, Florida. With the acquisition of the Scientific Air business, a recognized leader in its segment, Applied UV takes a significant step in transforming its business into a global healthcare infection control provider. 